|
1
|
Fahed J, Floyd KC and Tighe DA: Sudden
cardiac death in postmyocardial-infarction patients. Panminerva
Med. 57:2605–86. 2015.
|
|
2
|
Saaby L, Poulsen TS, Diederichsen AC,
Hosbond S, Larsen TB, Schmidt H, Gerke O, Hallas J, Thygesen K and
Mickley H: Mortality rate in type 2 myocardial infarction:
Observations from an unselected hospital cohort. Am J Med.
127:295–302. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ma S, Ma J, Mai X, Zhao X, Guo L and Zhang
M: Danqi soft capsule prevents infarct border zone remodelling and
reduces susceptibility to ventricular arrhythmias in
post-myocardial infarction rats. J Cell Mol Med. 23:5454–5465.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen RH, Li YG, Jiao KL, Zhang PP, Sun Y,
Zhang LP, Fong XF, Li W and Yu Y: Overexpression of Sema3a in
myocardial infarction border zone decreases vulnerability of
ventricular tachycardia post-myocardial infarction in rats. J Cell
Mol Med. 17:608–616. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huo L, Shi W, Chong L, Wang J, Zhang K and
Li Y: Asiatic acid inhibits left ventricular remodeling and
improves cardiac function in a rat model of myocardial infarction.
Exp Ther Med. 11:57–64. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wenk JF, Klepach D, Lee LC, Zhang Z, Ge L,
Tseng EE, Martin A, Kozerke S, Gorman JH III, Gorman RC and
Guccione JM: First evidence of depressed contractility in the
border zone of a human myocardial infarction. Ann Thorac Surg.
93:1188–1193. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu X, Wan N, Zhang XJ, Zhao Y, Zhang Y,
Hu G, Wan F, Zhang R, Zhu X, Xia H and Li H: Vinexin-β exacerbates
cardiac dysfunction post-myocardial infarction via mediating
apoptotic and inflammatory responses. Clin Sci (Lond). 128:923–936.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Takahashi T, Anzai T, Kaneko H, Mano Y,
Anzai A, Nagai T, Kohno T, Maekawa Y, Yoshikawa T, Fukuda K and
Ogawa S: Increased C-reactive protein expression exacerbates left
ventricular dysfunction and remodeling after myocardial infarction.
Am J Physiol Heart Circ Physiol. 299:H1795–H1804. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song G, Li X, Shen Y, Qian L, Kong X, Chen
M, Cao K and Zhang F: Transplantation of iPSc restores cardiac
function by promoting angiogenesis and ameliorating cardiac
remodeling in a post-infarcted swine model. Cell Biochem Biophys.
71:1463–1473. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang X, Zhu D, Wei L, Zhao Z, Qi X, Li Z
and Sun D: OSM enhances angiogenesis and improves cardiac function
after myocardial infarction. Biomed Res Int.
2015:3179052015.PubMed/NCBI
|
|
11
|
Yang L, Gregorich ZR, Cai W, Zhang P,
Young B, Gu Y, Zhang J and Ge Y: Quantitative proteomics and
immunohistochemistry reveal insights into cellular and molecular
processes in the infarct border zone one month after myocardial
infarction. J Proteome Res. 16:2101–2112. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiang F, Shi Z, Guo X, Qiu Z and Chen X,
Huang F, Sha J and Chen X: Proteomic analysis of myocardial tissue
from the border zone during early stage post-infarct remodelling in
rats. Eur J Heart Fail. 13:254–263. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang C, Zhang B, Lin Y and Dong Y: Effects
of adenovirus-mediated VEGF165 gene therapy on myocardial
infarction. Ann Clin Lab Sci. 48:208–215. 2018.PubMed/NCBI
|
|
14
|
Gu Y, Wu G, Wang X, Wang X, Wang Y and
Huang C: Artemisinin prevents electric remodeling following
myocardial infarction possibly by upregulating the expression of
connexin 43. Mol Med Rep. 10:1851–1856. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Spaulding K, Takaba K, Collins A, Faraji
F, Wang G, Aguayo E, Ge L, Saloner D, Wallace AW, Baker AJ, et al:
Short term doxycycline treatment induces sustained improvement in
myocardial infarction border zone contractility. PLoS One.
13:e01927202018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun F, Zhuang Y, Zhu H, Wu H, Li D, Zhan
L, Yang W, Yuan Y, Xie Y, Yang S, et al: lncRNA PCFL promotes
cardiac fibrosis via miR-378/GRB2 pathway following myocardial
infarction. J Mol Cell Cardiol. 133:188–198. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu H, Wu J, Li D, Zhou J, Yu H and Ma L:
Knockdown of lncRNA MALAT1 attenuates acute myocardial infarction
through miR-320-Pten axis. Biomed Pharmacother. 106:738–746. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu T, Wu D, Wu Q, Zou B, Huang X, Cheng X,
Wu Y, Hong K, Li P, Yang R, et al: Knockdown of long non-coding
RNA-ZFAS1 protects cardiomyocytes against acute myocardial
infarction via anti-apoptosis by regulating miR-150/CRP. J Cell
Biochem. 118:3281–3289. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hao S, Liu X, Sui X, Pei Y, Liang Z and
Zhou N: Long non-coding RNA GAS5 reduces cardiomyocyte apoptosis
induced by MI through sema3a. Int J Biol Macromol. 120:371–377.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kaikkonen MU, Halonen P, Liu OH, Turunen
TA, Pajula J, Moreau P, Selvarajan I, Tuomainen T, Aavik E, Tavi P
and Ylä-Herttuala S: Genome-wide dynamics of nascent noncoding RNA
transcription in porcine heart after myocardial infarction. Circ
Cardiovasc Genet. 10:e0017022017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ounzain S, Micheletti R, Beckmann T,
Schroen B, Alexanian M, Pezzuto I, Crippa S, Nemir M, Sarre A,
Johnson R, et al: Genome-wide profiling of the cardiac
transcriptome after myocardial infarction identifies novel
heart-specific long non-coding RNAs. Eur Heart J. 36:353–368a.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsuji M, Kawasaki T, Matsuda T, Arai T,
Gojo S and Takeuchi JK: Sexual dimorphisms of mRNA and miRNA in
human/murine heart disease. PLoS One. 12:e01779882017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. J R Statist Soc B. 57:289–300. 1995.
|
|
25
|
Dweep H and Gretz N: miRWalk2.0: A
comprehensive atlas of microRNA-target interactions. Nat Methods.
12:6972015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43((Database Issue)): D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kohl M, Wiese S and Warscheid B:
Cytoscape: Software for visualization and analysis of biological
networks. Methods Mol Biol. 696:291–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tang Y, Li M, Wang J, Pan Y and Wu FX:
CytoNCA: A cytoscape plugin for centrality analysis and evaluation
of protein interaction networks. Biosystems. 127:67–72. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Paraskevopoulou MD, Georgakilas G,
Kostoulas N, Reczko M, Maragkakis M, Dalamagas TM and Hatzigeorgiou
AG: DIANA-LncBase: Experimentally verified and computationally
predicted microRNA targets on long non-coding RNAs. Nucleic Acids
Res. 41((Database Issue)): D239–D245. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang DW, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jacobs M, Staufenberger S, Gergs U, Meuter
K, Brandstätter K, Hafner M, Ertl G and Schorb W: Tumor necrosis
factor-alpha at acute myocardial infarction in rats and effects on
cardiac fibroblasts. J Mol Cell Cardiol. 31:1949–1959. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Heba G, Krzemiński T, Porc M, Grzyb J and
Dembińska-Kieć A: Relation between expression of TNF alpha, iNOS,
VEGF mRNA and development of heart failure after experimental
myocardial infarction in rats. J Physiol Pharmacol. 52:39–52.
2001.PubMed/NCBI
|
|
33
|
Sato T, Fujieda H, Murao S, Sato H,
Takeuchi T and Ohtsuki Y: Sequential changes of hepatocyte growth
factor in the serum and enhanced c-Met expression in the myocardium
in acute myocardial infarction. Jpn Circ J. 63:906–908. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sato T, Tani Y, Murao S, Fujieda H, Sato
H, Matsumoto M, Takeuchi T and Ohtsuki Y: Focal enhancement of
expression of c-Met/hepatocyte growth factor receptor in the
myocardium in human myocardial infarction. Cardiovasc Pathol.
10:235–240. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang C, Bai X, Liu S, Wang J, Su Z, Zhang
W, Bu D, Yan Y and Song X: RNA-seq based transcriptome analysis of
the protective effect of compound longmaining decoction on acute
myocardial infarction. J Pharm Biomed Anal. 158:339–345. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee SJ, Lee CK, Kang S, Park I, Kim YH,
Kim SK, Hong SP, Bae H, He Y, Kubota Y and Koh GY: Angiopoietin-2
exacerbates cardiac hypoxia and inflammation after myocardial
infarction. J Clin Invest. 128:5018–5033. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Menichetti L, Kusmic C, Panetta D, Arosio
D, Petroni D, Matteucci M, Salvadori PA, Casagrande C, L'Abbate A
and Manzoni L: MicroPET/CT imaging of αvβ3 integrin via a novel
63Ga-NOTA-RGD peptidomimetic conjugate in rat myocardial
infarction. Eur J Nucl Med Mol Imaging. 40:1265–1274. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Furlani D, Klopsch C, Gäbel R, Ugurlucan
M, Pittermann E, Klee D, Wagner K, Li W, Wang W, Ong LL, et al:
Intracardiac erythropoietin injection reveals antiinflammatory
potential and improved cardiac functions detected by forced swim
test. Transplant Proc. 40:962–966. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Raut SK, Singh GB, Rastogi B, Saikia UN,
Mittal A, Dogra N, Singh S, Prasad R and Khullar M: miR-30c and
miR-181a synergistically modulate p53-p21 pathway in diabetes
induced cardiac hypertrophy. Mol Cell Biochem. 417:191–203. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Das S, Kohr M, Dunkerly-Eyring B, Lee DI,
Bedja D, Kent OA, Leung AK, Henao-Mejia J, Flavell RA and
Steenbergen C: Divergent effects of miR-181 family members on
myocardial function through protective cytosolic and detrimental
mitochondrial microRNA targets. J Am Heart Assoc. 6:e0046942017.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhu J, Wang FL, Wang HB, Dong N, Zhu XM,
Wu Y, Wang YT and Yao YM: TNF-α mRNA is negatively regulated by
microRNA-181a-5p in maturation of dendritic cells induced by high
mobility group box-1 protein. Sci Rep. 7:122392017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Corsetti PP, de Almeida LA, Gonçalves ANA,
Gomes MTR, Guimarães ES, Marques JT and Oliveira SC: miR-181a-5p
regulates TNF-α and miR-21a-5p influences gualynate-binding protein
5 and IL-10 expression in macrophages affecting host control of
Brucella abortus Infection. Front Immunol. 9:13312018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Korhan P, Erdal E and Atabey N:
miR-181a-5p is downregulated in hepatocellular carcinoma and
suppresses motility, invasion and branching-morphogenesis by
directly targeting c-Met. Biochem Biophys Res Commun.
450:1304–1312. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Dong N, Tang X and Xu B: miRNA-181a
inhibits the proliferation, migration, and epithelial-mesenchymal
transition of lens epithelial cells. Invest Ophthalmol Vis Sci.
56:993–1001. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wu RS, Wu KC, Yang JS, Chiou SM, Yu CS,
Chang SJ, Chueh FS and Chung JG: Etomidate induces cytotoxic
effects and gene expression in a murine leukemia macrophage cell
line (RAW264.7). Anticancer Res. 31:2203–2208. 2011.PubMed/NCBI
|
|
46
|
Ye Y, Zhao X, Lu Y, Long B and Zhang S:
Varinostat alters gene expression profiles in aortic tissues from
ApoE-/-mice. Hum Gene Ther Clin Dev. 29:214–225. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Du J, Yang ST, Liu J, Zhang KX and Leng
JY: Silence of lncRNA GAS5 protects cardiomyocytes H9c2 against
hypoxic injury via sponging miR-142-5p. Mol Cells. 42:397–405.
2019.PubMed/NCBI
|
|
48
|
Feng F, Qi Y, Dong C and Yang C: PVT1
regulates inflammation and cardiac function via the MAPK/NF-κB
pathway in a sepsis model. Exp Ther Med. 16:4471–4478.
2018.PubMed/NCBI
|
|
49
|
Yu YH, Hu ZY, Li MH, Li B, Wang ZM and
Chen SL: Cardiac hypertrophy is positively regulated by long
non-coding RNA PVT1. Int J Clin Exp Pathol. 8:2582–2589.
2015.PubMed/NCBI
|
|
50
|
Higashida H, Liang M, Yoshihara T, Akther
S, Fakhrul A, Stanislav C, Nam TS, Kim UH, Kasai S, Nishimura T, et
al: An immunohistochemical, enzymatic, and behavioral study of
CD157/BST-1 as a neuroregulator. BMC Neuroscience. 18:352017.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kannt A, Sicka K, Kroll K, Kadereit D and
Gögelein H: Selective inhibitors of cardiac ADPR cyclase as novel
anti-arrhythmic compounds. Naunyn Schmiedebergs Arch Pharmacol.
385:717–727. 2012. View Article : Google Scholar : PubMed/NCBI
|
